BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31233353)

  • 1. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
    Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
    J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
    Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
    Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features.
    Toner GC; Geller NL; Lin SY; Bosl GJ
    Cancer; 1991 Apr; 67(8):2049-57. PubMed ID: 1848473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
    Tarrant WP; Czerniak BA; Guo CC
    Hum Pathol; 2013 Oct; 44(10):2220-6. PubMed ID: 23856516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution.
    Takeda S; Miyoshi S; Ohta M; Minami M; Masaoka A; Matsuda H
    Cancer; 2003 Jan; 97(2):367-76. PubMed ID: 12518361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.
    Masterson TA; Shayegan B; Carver BS; Bajorin DF; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2012 Jan; 79(1):156-9. PubMed ID: 22202548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
    Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS
    Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases.
    Nwosu OI; Jones AJ; Alwani M; Einhorn LH; Moore MG; Mantravadi AV
    Laryngoscope; 2021 Jul; 131(7):1528-1534. PubMed ID: 33421136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after resection for metastatic testicular nonseminomatous germ cell cancer to the lung or mediastinum.
    Kesler KA; Kruter LE; Perkins SM; Rieger KM; Sullivan KJ; Runyan ML; Brown JW; Einhorn LH
    Ann Thorac Surg; 2011 Apr; 91(4):1085-93; discussion 1093. PubMed ID: 21440128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience.
    Rodney AJ; Tannir NM; Siefker-Radtke AO; Liu P; Walsh GL; Millikan RE; Swisher SG; Tu SM; Pagliaro LC
    Urol Oncol; 2012; 30(6):879-85. PubMed ID: 20933444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.
    Giannatempo P; Pond GR; Sonpavde G; Albany C; Loriot Y; Sweeney CJ; Salvioni R; Colecchia M; Nicolai N; Raggi D; Rice KR; Flack CK; El Mouallem NR; Feldman H; Fizazi K; Einhorn LH; Foster RS; Necchi A; Cary C
    J Urol; 2016 Jul; 196(1):95-100. PubMed ID: 26748165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mediastinal germ cell tumors - A retrospective analysis of >30 years of experience in a single institution.
    Koizumi T; Kanda S; Nihonmatu R; Gomi D; Sekiguchi N; Noguchi T; Fukushima T; Kobayashi T; Yamamoto H; Takeda T
    Thorac Cancer; 2021 Mar; 12(6):807-813. PubMed ID: 33502089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.
    De Backer A; Madern GC; Pieters R; Haentjens P; Hakvoort-Cammel FG; Oosterhuis JW; Hazebroek FW
    Eur J Pediatr Surg; 2008 Feb; 18(1):1-6. PubMed ID: 18302061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
    Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
    Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extragonadal germ cell tumors: prognostic factors and long-term follow-up.
    Aparicio J; Montalar J; Munárriz EB; Reynés G; Gómez-Codina J; Pastor M; Herranz C
    Eur Urol; 1995; 28(1):19-24. PubMed ID: 8521889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.